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Melanin pigment in mammalian skin is found primari-
ly in keratinocytes and melanocytes. While melanin
serves its primary function as photoprotective pigment in
the keratinocytes, its biosynthesis occurs in melanocytes
within specialized organelles known as melanosomes.
Human skin pigmentation is, in essence, a collective
manifestation of a complex cellular function of individual
melanocytes that begins with formation of tissue-specif-
ic precursor organelles, synthesis and ordered accumu-
lation of melanin polymer, directional transport of
pigmented melanosomes to the dendritic tips and their
eventual export to keratinocytes. Significant progress
has been made in understanding the molecular mecha-
nisms involved in these events, most notably in enzymat-
ic regulation of melanin synthesis, and in transport of
melanosomes to periphery. These topics have been
reviewed elsewhere and will not be discussed here
(Hearing 1999; Wu and Hammer 2000; Westbroek et al.
2001; Marks and Seabra 2001). More recently, new
exciting developments have also been reported in the
area of melanosome transfer to keratinocyte (Scott et al.
2001; Sieberg 2001; Minwalla et al. 2001). 
Within melanocytes, four distinct morphological
stages of melanosome maturation can be seen (Figure
1). Membrane vesicles containing no visible pigment but
irregular internal membrane structures are defined as
stage I or premelanosomes. Maturation of preme-
lanosomes to stage II melanosomes results in elongation
of the vesicles, and ordering of the internal membranes
into parallel structures. Stage III melanosomes can be
distinguished by the presence of ordered deposition of
melanin (sometimes appearing as beads on a string) on
the internal fibers. In mature, stage IV melanosomes
filled with melanin pigment no luminal structures are
distinguishable. This review will provide a brief account
of the history and continuing evolution of ideas on the
biogenesis of melanosomes, and provide a detailed
discussion of studies on the trafficking of individual
melanosomal membrane proteins, and ongoing molecu-
lar genetic and biochemical studies on mouse coat color
mutations and human pigmentary disorders that are
contributing to a better understanding of not only
melanosome biogenesis in health and disease but also
intracellular membrane dynamics in general. 
The Nature and Origin of Melanosome 
In this year of 50th anniversary of publication of DNA
structure (Watson and Crick 1953), it is of historical
significance to note that although the dark melanin
pigment granules were morphologically identified and
studied for long, the term “melanosome”, “a distinctive
subcellular particle of mammalian melanocytes and the
site of melanogenesis”, to describe the membrane
bound pigment granules was not proposed until 1961
(Seiji et al. 1961). While classical light and electron
microscopic studies helped to define the distinct stages
in morphological maturation of the melanosome (Mishi-
ma 1962), biochemical composition of the limiting
membrane and its biogenesis remained controversial.
This is illustrated by scattered reports that suggested
association of DNA with pigment granules and their
relationship to mitochondria (De Buy et al. 1949; Baker
et al. 1960). Application of subcellular fractionation and
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enzyme histochemical methods provided early indica-
tions of the relationship of melanosomes to Golgi and
lysosomes (Maul 1969), prompting Wolff and Honigs-
mann (1971) to raise the question “Are melanosome
complexes lysosomes?” over three decades ago. Analy-
sis of lysosomal function in inbred mice with coat color
mutations revealed that lysosomal dysfunctions are
associated with pigment gene mutations and led to the
suggestion that “…there are several critical genes in
mammals that control the biogenesis, processing and/or
function of related classes of subcellular organelles”
(Novak and Swank 1979). Two lines of investigation
have contributed significantly to our current understand-
ing of melanosome biogenesis, and its relationship to
other lysosomes-related organelles. These are a) cell
biological studies on intracellular sorting and transport of
melanosomal membrane proteins, specifically tyrosi-
nase, tyrosinase-related protein-1(Tyrp), p-protein and
Pmel17 (reviewed in Raposo and Marks 2002 and
Setaluri 2001), and b) molecular genetic analyses of
mouse coat color mutations and a group of human
pigmentary disorders, specifically Chediak-Higashi
syndrome (CHS) and Hermansky-Pudlak syndrome
(HPS) (Spritz 2000; Starcevic et al. 2002; Ward et al.
2002). The availability of mouse and human melanoma
cell lines that retain differentiated phenotype and the
ease of culturing mouse and human melanocytes have
made melanosome an excellent model for understanding
biogenesis of lysosome-related organelles.
Melanosome biogenesis: More than skin deep
Unraveling melanosome biogenesis has broader
implications than simply understanding how melanin
pigment is packaged. In mammals, the cellular machin-
ery for biogenesis of melanosomes has emerged primar-
ily in two groups of pigment cells i.e., cutaneous and
uveal melanocytes derived from the neural crest, and the
retinal pigment epithelial (RPE) cells derived form the
neuroectoderm. Although these two groups of
melanocytes are generally thought to be derived from
different embryonic tissues (Dupin and Le Douarin 2003;
Schraermeyer and Heimann 1999), it has been argued
that a single progenitor in the neural tube could give rise
to both neural crest and optic neuroectoderm
melanoblasts (Boissy 1998). Defining precise embryonic
origin of these two types of pigment cells has implica-
tions for understanding molecular regulation of
melanosome biogenesis during development. Regard-
less of their origin, the limited and transient ability to
produce melanosomes distinguishes ocular pigment
cells (both uveal and RPE) from their cutaneous counter-
parts, which produce melanosomes continually through-
out life (Feeney-Burns 1980). This difference between
ocular and cutaneous pigment cells might hold clues to
master genetic switches that regulate melanosome
biogenesis. In addition to ocular pigment abnormalities
associated with the well characterized oculocutaneous
albinsms, mutations in genes encoding melanosomal
proteins have recently been shown to be associated with
other ocular diseases such as pigmentary glaucoma
(Anderson et al. 2002; Libby et al. 2003).
Presence of melanosomes and/or expression of
melanosomal antigens is used in diagnosis of pigmented
lesions and abnormal differentiation of amelanotic lesions
and occasionally for prognosis of certain melanomas
(Yen et al. 2000; Suzuki et al. 2001). Moreover, in
patients with autoimmune vitilgo and malignant
melanoma, melanosomal proteins are frequent targets for
both humoral and cellular immune responses (Kemp et
al. 2001; Ramirez-Montagut et al. 2003; Raposo et al.
2002; Sakai et al. 1997). Involvement of endosomes in
melanosome biogenesis, and intersection of melanoso-
mal protein trafficking with intracellular pathways of
antigen processing seems to facilitate preferential
immune responses to these proteins (Wang et al. 1999).
Melanosome is also considered a perfect model for cellu-
lar responses to environment (Hearing 2000).
Pathways to melanosome biogenesis
The earliest theory on the pathway of melanosome
biogenesis was formulated by exploiting the ability to
localize tyrosinase activity in various cellular compart-
ments by ultrastructural enzyme histochemical methods
(Seiji et al. 1961a, 1963). It was proposed that preme-
lanosomal (stage I) vesicles containing luminal matrix
proteins bud from smooth endoplasmic reticulum (ER),
and mature to form elongated stage II melanosomes with
the characteristic luminal parallel arrays of fibers. Fusion
of trans-Golgi derived clathrin-coated, tyrosinase-
containing coated vesicles with stage II melanosomes
was proposed to initiate synthesis and deposition of
melanin and produce mature melanosomes. This view
gained support from the biochemical characterization of
Pmel17/gp100, a melanosomal membrane protein
encoded by the mouse silver locus.
Based on the absence of Golgi-modifi-
cations of Asn-linked sugars of Pmel17,
it was argued that this luminal protein
and vesicles enriched with this protein,
presumably premelanosomes, arise
directly from the ER (Kobayashi et al.
1994). However, unlike its mouse
counterpart, human Pmel17 is glycosy-
lated and undergoes maturation in the
Golgi (Berson et al. 2001). This obvious-
ly raises the question whether Pmel17 is
a valid marker of premelanosmes.
However, detailed ultrastructural studies
on Pmel17conatining vesicles have
provided an alternative view of the
nature and origin of premelanosomes
(Raposo et al. 2001). Pmel17 is found
Figure 1. Morphology of melanosome maturation. Transmission electron micro-
graph of pigmented human melanoma cell line SK-MEL-19 showing
different stages in melanosome biogenesis and maturation. Endosome-
like structures containing internal vesicles and nascent fibrils are consid-
ered melanosomal precursors or stage I melanosomes. Reorganization
and/or structured deposition of fibrils and elongation of the spherical
vesicles into stage II melanosmes is followed by ordered deposition
melanin (stage III) and its accumulation that eventually fills in the lumen
(stage IV) can be clearly demonstrated.
enriched in intraluminal vesicles of multivesicular
compartment with dense clathrin coat, but absent in
trans-Golgi network (TGN) and clathrin-coated vesicles.
Conversely, tyrosinase and tyrosinase related protein 1
(TRP-1/gp75), which are present in TGN and clathrin-
coated vesicles, are absent in Pmel17 enriched vesicles.
This Pmel17 enriched, multivesicular, coated endosomal
compartment at the intersection of TGN, the early and
late endosomes was proposed to represent pre-/stage I
melanosome. Reorganization of the luminal fibrillar
structures into parallel arrays seems to produce the
characteristic stage II melanosmes. Other melanosomal
proteins including tyrosinase and TRP-1 are then appear
to be delivered to stage II melanosomes directly from the
TGN via clathrin-coated vesicles. Interestingly, expres-
sion of Pmel17 in non-melanocytic cells is sufficient to
produce multivesicular endosomes with internal struc-
tures similar to fibrils in stage II melanosomes, suggest-
ing that Pmel17 plays a critical role in the biogenesis of
luminal structures of melanosomes (Berson et al. 2001).
Although a role for multivesicular bodies in melanosome
formation in fish was reported earlier (Turner et al. 1975),
it now appears that similar multivesicular bodies play a
role in melanosome biogenesis in mammals. Using free-
flow electrophoresis, a method to separate various
subcellular organelles, Kushimoto et al. (2002) reported
that whereas Pmel17/gp100 is clearly present in stage I
melanosomes, tyrosinase and other melanosomal
proteins are also detectable in such vesicles. The highly
proteolytic environment in these vesicles seems to
degrade or partially cleave these proteins and impair
their enzymatic activity, whereas this very environment
may be necessary to cleave Pmel17 and restructure
premelanosomes. The reasons for this discrepancy
between these studies on the presence of tyrosinase
and TRP-1 in early stage I melanosomes are not yet
understood.
We have been investigating trafficking
of human TRP-1 and its role in
melanosome biogenesis (Vijayasaradhi
et al. 1991, 1995, Liu et al. 2001, 2002).
Although TRP-1 is known to influence
melanosome morphology, its exact role
in the biogenesis of this organelle is not
clear. Based on ultrastructural studies of
hair bulb melanocytes in brown coat
color mice expressing mutant alleles of
b-locus, it was proposed that TRP-1 influ-
ences the size and shape of the pigment
granules, specifically the internal struc-
ture in stage III melanosomes (reviewed
in Silvers 1979; Sarangarajan and Boissy
2001). Melanin pigment in b-granules is
flocculent and coarsely granular
compared to homogeneous and finely
granular appearance in black granules
(Silvers 1979). In humans, loss of
expression of TRP-1 due to a single base
pair deletion is known to cause type 3
oculocutaneous albinism (OCA3), identi-
fied in a newborn hypopigmented
African-American twin (Boissy et al.
1996). The affect of this mutation on
melanosome biogenesis has not been
investigated.
We exploited a system of selective and reversible
inhibition of endogenous TRP-1 transcription in human
melanoma cells to investigate the role of TRP-1 in
melanosome biogenesis (Vijayasaradhi et al. 1995a;
Fang et al. 2002). In pigmented human melanoma cell
lines treated with the pharmacological compound,
hexamethylene bisacetamide (HMBA), TRP-1 expres-
sion is completely suppressed and melanosomes exhib-
it many structural abnormalities (Figure 2, Setaluri
unpublished observations). In control untreated cells,
most melanosomes appear elliptical in longitudinal
cross-section (LC), and circular in cross-sectional (CS)
view, and melanin is deposited in uniform fashion. In
HMBA treated cells, TRP-1 depleted melanosomes are
curved and distended in LC, and dented in CS. Melanin
is deposited in an uneven fashion. Defects in
melanosome biogenesis are also evident. In light of the
observation that TRP-1 is the most abundant melanoso-
mal protein, these observations suggest a role for TRP-
1 in the maintenance of melanosome membrane
(Vijayasaradhi et al. 1991; Sarangarajan and Boissy
2001).
Melanosomal protein sorting: 
Signals and adaptors
The TGN is a key sorting station from where proteins
traveling along the secretory pathway are sorted to
various cellular destinations via transport vesicles. A
large body of evidence accumulated to date shows that
sorting of integral membrane proteins in the TGN is
dependent on short stretches of amino acid residues
within the cytoplasmic domains of proteins (reviewed in
Kirchhausen et al. 1999). The most commonly found
signals are tyrosine-based signals and di-leucine motif
signals (Williams and Fukuda 1991; Ogata and Fukuda
1994; Vijayasaradhi et al. 1995). A di-leucine containing
motif and a glutamic acid residue located 3-4 residues
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Figure 2. Melanosome structure and role of TRP-1. Ultrastructure of
melanosomes in TRP-1 positive and TRP-1 depleted human pigmented
melanoma cell line. In control cells, characteristic structures representing
various stages of melanosome maturation can be seen. Cells treated
with hexamethylene bisacetamide, which completely extinguishes TRP-1
expression, show accumulation of small vesicles near stage II and III
melanosomes, and melanosomal abnormalities such as “sickle-like”
appearance and uneven melanin deposition.
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amino terminal to the di-leucine motif are conserved not
only among other type I melanosomal proteins but also
in a type III melanosomal protein (Vijayasaradhi et al.
1995). A role for these signals in the cytoplasmic tails in
sorting melanosomal proteins in vivo is supported by two
observations. First, the platinum mutant allele of mouse
tyrosinase gene, which codes for truncated protein
lacking the di-leucine motif, causes improper targeting of
tyrosinase (Chintamaneni et al. 1991 and Beerman et al.
1995). Second, mutations in subunits of adaptor
complexes AP-3, which bind the di-leucine motif (see
below) produce coat color mutations mocha and pearl,
and are responsible for the hypopigmentary disorder in a
subset of individuals with Hermansky-Pudlak like
syndrome (Kantheti et al. 1998; Feng et al. 1997;
Dell’Angelica et al. 1999; Spritz 2000). 
Although the di-leucine signal is both necessary and
sufficient for intracellular sorting of tyrosinase and TRP-
1, tyr-based signals (specifically Y-X-X-Ø where Ø is
bulky hydrophobic amino acid), present in TRP-1 and
TRP-2 may also play a role in melanosomal protein
sorting (Simmen et al. 1999). This raises the possibility
that melanosomal proteins may follow alternative paths
to the melanosome by utilizing tyr-based sorting signals
and clathrin adaptor complex AP-1 recognition for sorting
in the TGN, and AP-2 mediated sorting for internalization
from plasma membrane (Ohno et al. 1996, 1998). Anoth-
er possibility is that the tyr-based signals are utilized to
retrieve mis-targeted melanosomal protein (Vijayasarad-
hi et al. 1995). Melanosomal proteins may also utilize
signals different from tyr- and di-leucine signals is
indicated by the absence of di-leucine motifs in TRP-2,
and the OA1protein (a type III membrane protein encod-
ed by the ocular albinism type I gene (Schiaffino et al.
1996). Conversely, presence of di-leucine motif does not
appear to completely prevent targeting melanosomal
proteins to other cellular locations including plasma
membrane (Xu et al. 1997). 
Clathrin-coated vesicles play a critical role in the
transport of cellular cargo from the TGN and between
endosomal compartments in all cell types (reviewed in
Brodsky et al. 2001). So, what mechanisms do
melanocytes utilize to enrich melanosomal cargo in
clathrin-coated vesicles? How are such vesicles targeted
to fuse selectively with pre- and/or stage II-
melanosomes? An insight into these issues came from
molecular genetic analyses of mouse coat color
mutations and human hypopigmentary disorders.
It in now established that coat colors of mocha and
pearl mutant mice and hypopigmentary disorder in a
subset of patients with the Hermansky-Pudlak syndrome
(HPS2) (Kantheti et al. 1998; Feng et al. 1997; Dell’An-
gelica et al. 1999; Spritz 2000) (and also a pigmentary
defect in the eyes of fruit fly Drosophila) are caused by
defects in specific subunits of the adaptor complex AP3.
This tetrameric complex, expressed ubiquitously, binds
to clathrin as well as the di-leucine motif in the cytoplas-
mic tails of melanosomal and lysosomal proteins. In both
human HPS and mouse models, mislocalization of
lysosomal proteins and tyrosinase is also accompanied
by defects in platelet dense granules (Huizing et al.
2000; Swank et al. 2000). While localization of the
misrouted tyrosinase in AP-3 deficient, HPS
melanocytes to large multivesicular compartment is
consistent with a defect in endosomal sorting, it is not
clear whether sorting from the TGN is also affected. The
complexity of these sorting events and the possible role
of additional cytoplasmic proteins in early sorting steps
are highlighted by the following observations. First,
although AP3 is expected to bind TRP-1, in which the
canonical di-leucine motif was first identified, in AP-3
deficient cells, sorting and targeting of TRP-1 to
endosomes/melanosomes is not affected (Huizing et al.
2001). Second, newly synthesized TRP-1, but not tyrosi-
nase, transiently binds to a cytoplasmic PDZ domain
protein, GIPC, suggesting a role for this interaction in
TRP-1 sorting (Liu et al. 2001). However, it is not clear
whether the TRP-1-GIPC interaction occurs in the TGN
or the endosomes or whether this interaction precedes
or follows the di-leucine mediated sorting step. Interest-
ingly, GIPC also interacts with GAIP, a clathrin-vesicle
resident regulator of Gia (De Vries et al. 1998), suggest-
ing a possible role for G-protein signaling in early
melanosomal protein sorting events (see below). These
observations highlight the role specific protein-protein
interactions between melanosomal membrane proteins
and cytosolic proteins play at different sorting and target-
ing steps.
Melanosome biogenesis: 
The lysosome connection
The involvement of endosomes in melanosome
biogenesis places these organelles in the midst of a
highly dynamic biosynthetic and endocytic vesicular
traffic that shuttles cargo to a variety of subcellular
compartments including lysosomes (Sachse et al. 2002).
But, what is the relationship of melanosomes to
lysosomes? Are melanosomes specialized lysosomes?
Can lysosomes be distinguished from melanosomes in
melanocytes? Earliest indications of a relationship
between these organelles came from the morphological
Figure 3. Segregation of lysosomal and melanosomal
proteins. Immunoelectron microscopic localization
of TRP-1 and LAMP-1. Ultrathin cryosections of
mouse fibroblasts transfected with human TRP-1
were incubated with anti-TRP-1 mAb conjugated to
10nm gold particles and anti-LAMP-1 mAb conjugat-
ed to 5nm gold particles. Endosomal vesicle
enriched with TRP-1 (A) or enriched with LAMP-
1(arrow in B) could be seen. Arrows in A show
fusion of TRP-1 enriched vesicles, internalization
and intraluminal TRP-1. Arrowhead in B shows
segregation of TRP-1 from LAMP-1 enriched
vesicles, suggesting presence of mechanisms to
target TRP-1 to specialized endosomes in non-
melanocytic cells.
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(enzyme cytochemistry) and biochemical (subcellular
fractionation) studies that showed presence of several
lysosomal hydrolases in melanosomes. Co-localization
of melanosomal proteins and lysosomal membrane
proteins in non-melanocytic cells transfected with
melanosomal membrane proteins, specifically tyrosinase
and TRP-1, appeared to support the view that
melanosmes are modified lysosomes (Orlow 1995).
Although melanosomes are lysosome-related
organelles, they are readily distinguished from
lysosomes, based on their unique morphology and
enrichment of specific membrane proteins (Raposo et al.
2001). Indeed, it appears that mechanisms to segregate
melanosomal membrane protein TRP-1from lysosomal
membrane protein LAMP-1 exist in both melanocytic and
non-melanocytic (Fujita et al. 2001 and Fig. 3, Setaluri
unpublished observations). Immunoelectron microscopic
studies of TRP-1 expressed in non-melanocytic cells
showed the presence of three distinct types of vesicles
based on the distribution of different size gold particles (5
and 10-nm) representing LAMP-1 and TRP-1. Type I
vesicles containing both 5-and 10-nm gold particles,
hence both TRP-1 and LAMP-1, represented a majority
of labeled vesicles. Type II vesicles contained almost
exclusively 5-nm gold particles (LAMP-1), while type III
structures had mostly 10-nm gold particles (TRP-1)
(Table I in Setaluri 2000). LAMP-1 enriched, type II struc-
tures were also distinguishable by an electron-dense
core. These observations suggest that while TRP-1 and
LAMP-1 (an endosome/lysosome marker) are colocal-
ized in several cytoplasmic structures, presumably
sorting endosomes, vesicles that are enriched for TRP-1
are present even in non-melanocytic cells. This is
consistent with a view that following initial export of
melanosomal and lysosomal proteins from the TGN to a
common endosomal compartment by AP-1/AP-3 mediat-
ed sorting, additional signals and sorting mechanisms
then segregate melanosomal proteins from late
endosome/lysosome traffic. In melanocytic cells,
budding of vesicles selectively enriched for melanosomal
or lysosomal proteins, and fusion of such vesicles with
melanosomes and late endosome/prelysosome, respec-
tively, could generate and maintain the integrity of these
specialized organelles (Figure 4). It is also possible that
selective export of lysosomal proteins out of a common
endosome, allows maturation of melanosomal protein-
enriched structures to stage II melanosomes. Melanoso-
mal proteins that are mistargeted could be retrieved into
the coated endosomes by retrograde transport mecha-
nisms similar to the Golgi-to-ER transport. Alternatively,
mistargeted melanosomal proteins could be exchanged
between late endosomes/lysosomes and stage II
melanosomes. For example, in secretory cells, mistar-
geted mannose 6- phosphate receptors are retrieved
from secretory granules by AP-1 mediated sorting
mechanisms and then delivered to endosomes
(Klumperman et al. 1998). 
Defects in any one of these steps would be expected
to result in failure to maintain integrity of melansomes
and lysosomes. Chediak-Higashi syndrome (CHS), an
autosomal recessive pigmentary disorder in humans,
and beige coat color mutation of mice, appear to repre-
sent such scenario. A defect in secretory lysosome
function produces abnormally enlarged or abnormally
small lysosomes in the affected cell types, specifically
lymphocytes and melanocytes. Although the gene and
its protein product associated with CHS/beige have been
identified, no specific function in vesicular transport has
been assigned (Burkhardt et al. 1993; Baetz et al. 1995;
Barbosa et al. 1999; Perou et al. 1996).
Recently,Tchernev et al. (2002) reported that the CHS
protein interacts with several proteins, such as SNARE
complex (see below), important in vesicular transport
and signal transduction
Two observations point to a possible function(s) of
Lyst protein in endosomal/lysosomal protein transport: a)
Overexpression of wild type protein in CHS1 mutant
fibroblasts results production of abnormally small
lysosomes, suggesting that lyst protein is involved in
vesicle budding from endosomes/lysosome (Perou et al.
1996). b) Although the function of specialized secretory
lysosomes is impaired in cells affected by CHS, endocyt-
ic and degradative functions of endosomes/lysosomes
appears to be intact (Perou et al. 1997). It is possible
that, in CHS/beige melanocytes, defects in budding
mechanisms prevent endosomal sorting of melanosomal
and lysosomal proteins resulting in large melano-
lysosomes and pigment dilution (Spritz 1998). Interaction
of CHS protein with signal transduction components
raises the possibility that this protein provides a link
between melanosome biogenesis and signaling
pathways.
How to assemble a melanosome? 
By Rabs and SNAREs, of course!
The precise biochemical details of how vesicles
enriched in melanosomal proteins are targeted to fuse
selectively with melanosomal structures? However, it is
now clear that all eukaryotes, yeast to man, utilize a
combination of COPs (vesicle coat associated proteins),
SNAREs (soluble N-ethylmaleimide-sensitive factor
attachment protein receptors) and a family of small
GTPases of the Ras superfamily to orchestrate vesicle
budding and fusion events between different membrane
compartments (Whyte and Munro 2002; Seabra et al.
2002). Therefore, it is reasonable to assume that same
general principles that regulate vesicular trafficking in
vacuolar system also control melanosome biogenesis.
For example, in mouse coat color mutant gunmetal, a
coat color phenotype and a mouse model of HPS with
accompanying platelet dense granule defects, is associ-
ated with mutations in Rab geranylgeranyl transferase
(Detter et al. 2000), and in chocolate mutant mice,
mutation of Rab38 results in impaired targeting of TRP-
1 (Loftus et al. 2002). Interestingly, Rab7, which is local-
ized to late endosomes, may also be involved in traffick-
ing of tyrosinase and TRP-1 from TGN to melanosomes
(Gomez et al. 2001; Hirosaki et al. 2002) 
A role for SNAREs in melanosome biogenesis is also
emerging. According to the SNARE hypothesis, the
specificity of vesicle fusion is regulated by recognition
between SNAREs present on the transport vesicle (v-
SNAREs) and their cognate SNAREs (t-SNAREs) on the
target membrane compartments (Banfield 2001; Chen
and Scheller 2001; Pelham 2001). The SNARE hypothe-
sis was originally proposed based on the cycling of
synaptic vesicles (Rizo and Sudhof 2002). SNARE
complexes typically consist of a syntaxin, a vesicle-
associated membrane protein (VAMP) and two synapto-
some-associated proteins (SNAPs) These SNARE
complex proteins, which are expressed in all eukaryotic
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cells, also appear to play a role in melanosome biogen-
esis. For example, the product of pallidin, the mouse
gene associated with pigmentation defects, platelet
dense granule deficiency and emphysematous lungs in
adult animals, binds to synatxin 13, a member of the
syntaxin family of SNARE proteins (McGarry et al. 1999;
Huang et al. 1999). Synatxin 13 is localized to tubular
extensions of early endosomes, recycling endosomes
and clathrin-coated endosomes (Prekeris et al. 1998).
Based on the morphological similarity of endosomal
intermediates involved in melanosome biogenesis with
coated endosomes, and the requirement of syntaxin 13
in homotypic endosome-endosome fusion, it is conceiv-
able the syntaxin 13-pallidin could function as a preme-
lanosmal t-SNARE (McBride et al. 1999; Falcon-Perez
and Dell’angelica 2002). Other melanosome-associated
SNAREs include syntaxin 4, SNAP-23 and SNAP-25
(Scott and Zhao 2001).
In addition to the general SNARE-like biochemical
machinery for fusion of melanosomal cargo vesicles with
premelanosome, other melanocyte-specific proteins may
also be involved in regulation of these steps. P protein,
which is a 12-transmembrane domain containing trans-
porter protein, may play such regulatory role. Mutations
in the gene encoding this protein are responsible for
human OCA2 and the mouse pink-eyed dilute pheno-
type. Brilliant (2001) proposed that a defect in the anion
transport function of the P protein, which results in failure
of acidification of transport vesicles, causes accumula-
tion and/or mistargeting of melanosomal proteins to
lysosomal compartments. The exact biochemical
mechanisms through which P protein regulates
melanosome biogenesis remains to be defined.
Hermansky-Pudlak Syndrome: 
A treasure trove for vesicle biogenesis
Molecular identification of genes and their protein
products associated with of HPS, a collection of autoso-
mal recessive genetic disorders characterized by oculo-
cutaneous albinism, ceroid accumulation in lysosomes
and prolonged bleeding, is helping unravel the biochem-
ical machinery involved in the biogenesis of lysosome-
related organelles (Huizing et al. 2002; Starcevic 2002).
In mice, there are at least 16 distinct genetic loci that
produce coat color mutant phenotypes and associated
HPS-like platelet deficiencies (Swank et al. 1998). As
mentioned earlier, HPS type 2 and the mouse mutation
pearl is associated with b3A subunit of AP-3 complex
(Feng et al. 1999). Genes associated with HPS-1, -3, -4,
-5 and -6 and their mouse orthologues pale ear, cocoa,
light ear, ruby eye 2, and ruby eye
respectively have been identified (Gwynn
et al. 2000; Suzuki et al. 2001a, 2002;
Zhang et al. 2003). Proteins encoded by
these genes do not have any recogniz-
able motifs that suggest their biochemi-
cal functions. Recent data shows that
these proteins occur as complexes,
termed BLOCs (biogenesis of lysosome-
related organelles complex). BLOC-1
complex consists of the HPS related
mouse pallid (pa), muted (mu) and
cappucino (cno) proteins (Falcon-Perez
et al. 2002), whereas HPS5 and HPS6
proteins form BLOC-2, and HPS1 and
HPS4 proteins appear to be components
of BLOC-3 and BLOC-4 (Chiang et al.
2003). Based on the observation that
BLOC-1 is able to associate with actin
filaments, it was proposed that this inter-
action with actin may be involved in the
mechanism of BLOC-1 action in the
biogenesis of lysosome related
organelles. The specific roles played by
the other BLOCs in the biogenesis of
melanosomes remain to be determined.
Are BLOCs novel SNARES? By virtue of
their association with the cytoplasmic
face, do BLOCs mediate communication
with cellular signaling pathways that
regulate vesicular traffic? 
Cellular signaling and
melanosome biogenesis 
A variety of cellular signaling
pathways including cyclic AMP, protein
kinase C, and phosphatidylinositol 3-
kinase (PI3K) are known to influence
melanin pigment synthesis (Abdel-Malek
et al. 1992; Berlotto et al. 1998; Park et
Figure 4. Melanosome biogenesis and its relationship to endosomes. A
simplified scheme of primary pathways of protein sorting and transport,
and the involvement of shared endosomal compartments in the biogene-
sis of lysosomes and melanosomes. EE: early endosomes; LE: late
endosomes; TGN: trans-Golgi network. Solid arrows indicate pathways
of melanosomal protein transport and progressive maturation of
melanosomes. Arrows with dotted lines show biosynthetic and endocytic
protein transport of lysosomal proteins through sorting and early
endosomes to prelysosomes and lysosomes. Arrow with dashed line
indicates transport of proteins targeted to the cell surface. Although the
vesicular transport steps are shown as unidirectional, bidirectional trans-
port can occur to facilitate membrane recycling and retrieval of mistar-
geted proteins. The multivesicular endosomal compartment immediately
distal to the TGN is shown to represent pre- or stage I melanosome with
characteristic fibrils shown in Fig.1.
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al. 1999; Oka et al. 2002). Whereas activation of cyclic
AMP and protein kinase C pathways are generally
known to activate or increase the expression of tyrosi-
nase, PI3K signaling may be involved in melanosome
biogenesis. PI3K is a member of a family of kinases that
phosphorylate the membrane phospholipid,
phosphatidylinositol. Phosphatidyl- inositol 3-phosphate
(PI3P) generated by PI3K, which is localized in the
cytoplasm, has been shown to influence endosomal
membrane trafficking. PI3P appears to function by
recruiting cytsolic effector proteins to the endosomal
membrane (Odorizzi et al. 2000). Interestingly, in yeast
the single isoform of PI3K enzyme is coded by the gene
vps34, a member of a large family of more than 50 genes
that are involved in vacuolar protein sorting (reviewed in
Katzman et al. 2002). In mammalian cells, PI3K activity
is required for protein trafficking and endosomal vesicu-
lar biogenesis. This is illustrated by the observation that
injection of anti-human PI3K antibodies into cultured
human cells or treatment with wortmannin, an inhibitor of
PI3K activity, inhibits biogenesis of multivesicular bodies
(Futter et al. 2001). Based on the intracellular distribution
of TRP-1 in human melanoma cells treated with
wortmannin, an inhibitor of PI3K, Chen et al. (2001)
suggested that PI3K plays a role in trafficking of TRP-1
from late endosomes to melanosomes. Our preliminary
observations that the PDZ protein GIPC, which binds to
newly synthesized TRP-1, also interacts with a cytosolic
signaling adaptor APPL (Mitsuuchi et al. 1999; Liu et al.
2002), containing multiple protein domains, including a
phosphotyrosine binding (PTB) domain indicates a
possible link between PI3K signaling and melanosome.
In melanocytes and melanoma cell lines, inactive Akt2,
the primary downstream target for activation by PI3K, is
bound to the PTB domain of APPL (Liu et al. 2002a).
This raises the possibility that an interaction of the TRP-
1 cytoplasmic tail with GIPC-APPL-Akt2 complex might
mediate regulation of TRP-1 trafficking by PI3K. 
Additionally, interaction of GIPC with GAIP (a regula-
tor of G-protein Gai3), which is localized to clathrin-
coated vesicles, implicates GIPC in linking melanosome
biogenesis to G-protein signaling. The notion that G-
protein signaling may regulate melanosome biogenesis
is supported by the findings that mutations in OA1, a
melanosome-resident G-protein-coupled receptor, result
in enlarged melanosomes and cause ocular albinism
(OA) in both mice and humans (Schiaffino et al. 1999;
Incerti et al. 2000; Shen et al. 2001). Biochemical
mechanisms through which G-protein signaling influence
melanosome biogenesis remain to be identified. 
Apart from the melanocyte intracellular factors
described above, several other factors including
neuropeptides and certain therapeutic agents also influ-
ence melanosome biogenesis. Calcitonin gene-related
peptide, a neuropeptide, seems to increase melanosome
number, presumably by affecting their biogenesis, in skin
organ cultures but not in isolated culture melanocyte
(Toyoda et al. 1999). In mice, cyclophosphamide, a
cancer chemotherapeutic alkylating agent, has been
reported to induce disordered formation of melanosomes
in hair bulb melanocytes (Slominski et al. 1996). Treat-
ment of B16 mouse melanoma cells with paclitaxel, a
microtubule stabilizing chemotherapeutic agent, on the
other hand, increases number of melanosomes
(Bicamumpaka and Page 1998). 
Concluding Remarks
Melanosomes, long thought to represent merely
membrane sacs that contain and transport pigment, are
now attracting unprecedented attention of investigators
from a wide range of basic and clinical disciplines includ-
ing cell biology, molecular genetics, hematology, and
tumor immunology. A collection of human oculocuta-
neous syndromes associated with a wide range of other
clinical features, and their orthologues in a seemingly
unending resource of mouse coat color mutants have
proved valuable. This has led to the identification of an
unprecedented number of novel genes involved in the
biogenesis of lysosome-related organelles. The exact
functions of many these proteins and their mechanisms
of action remain to be discovered. Although melanin
pigment granules are related to lysosomes, as they were
long suspected, it is now established that melanosomes
are distinct organelles. Melanocyte-specific proteins
originally thought to be primarily involved in melanin
pigment synthesis are now being assigned novel
functions in vesicle biogenesis and roles in other ocular
diseases. Many other pieces are required to complete
the melanosome puzzle. For example, are there master
regulatory switches, genetic and/or epigenetic, that
regulate melanosome biogenesis? What are the mecha-
nisms that link melanosome biogenesis to intracellular
signaling? The recent attention these dark pigment
granules have received is a cause for optimism that it will
continue to shine brighter light on these and many other
aspects of melanocyte biology in health and disease. 
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